Literature DB >> 7164252

Dynamic behavior of plasma phosphate in chronic dialysis patients.

H Sugisaki, M Onohara, T Kunitomo.   

Abstract

1. Change in the plasma P concentration during intra- and interdialytic phases is notably different from that for BUN, CR and UA. Reduction rate for P depends on its pretreatment concentration. Plasma P is apt to level off or rebound even during a treatment and quickly returns to the pretreatment level after it is terminated. 2. In short-term evaluations, occurrence of P rebound during a treatment does not correlate with factors such as meal, A1 gel, dialyzer type, dialyzer membrane and therapeutic mode, but with the pretreatment P concentration. Once it reaches a threshold level inherent to each patient, plasma P seems to rebound. 3. Pretreatment P concentration in each patient seemed to be controlled in a relatively narrow range. 4. While apparent generation rates (G) estimated with a single compartmental kinetic model are stable during intra- and interdialytic phases as to BUN, CR and UA, G for P seems to be significantly enhanced especially during the latter period of the treatment and immediately after the termination of the treatment.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7164252

Source DB:  PubMed          Journal:  Trans Am Soc Artif Intern Organs        ISSN: 0066-0078


  5 in total

1.  A two-pool kinetic model predicts phosphate concentrations during and shortly following a conventional (three times weekly) hemodialysis session.

Authors:  John T Daugirdas
Journal:  Nephrol Dial Transplant       Date:  2018-01-01       Impact factor: 5.992

2.  Kinetic model of phosphorus mobilization during and after short and conventional hemodialysis.

Authors:  Baris U Agar; Alp Akonur; Ying-Cheng Lo; Alfred K Cheung; John K Leypoldt
Journal:  Clin J Am Soc Nephrol       Date:  2011-10-27       Impact factor: 8.237

3.  Postdialysis serum phosphate equilibrium in hemodialysis patients on a controlled diet and no binders.

Authors:  Elizabeth R Stremke; Laurie Trevino; Simit Doshi; Ranjani N Moorthi; Kathleen M Hill Gallant; Sharon M Moe
Journal:  Hemodial Int       Date:  2021-12-28       Impact factor: 1.543

4.  Intracellular Phosphate Dynamics in Muscle Measured by Magnetic Resonance Spectroscopy during Hemodialysis.

Authors:  Sandrine Lemoine; Thomas Fournier; Gabriel Kocevar; Amélie Belloi; Gabrielle Normand; Danielle Ibarrola; Dominique Sappey-Marinier; Laurent Juillard
Journal:  J Am Soc Nephrol       Date:  2015-11-11       Impact factor: 10.121

5.  EOS789, a broad-spectrum inhibitor of phosphate transport, is safe with an indication of efficacy in a phase 1b randomized crossover trial in hemodialysis patients.

Authors:  Kathleen M Hill Gallant; Elizabeth R Stremke; Laurie L Trevino; Ranjani N Moorthi; Simit Doshi; Meryl E Wastney; Nozomi Hisada; Jotaro Sato; Yoshitaka Ogita; Naohisa Fujii; Yuya Matsuda; Takei Kake; Sharon M Moe
Journal:  Kidney Int       Date:  2020-10-31       Impact factor: 10.612

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.